Metraipolis › archive › dc_bb82169d4aea

New-Onset Autoantibody-Negative Diabetes With DKA Following Lorlatinib Therapy for ALK-Positive NSCLC — Europe PMC PMID:41322009

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41322009
DOI
10.1155/crie/8034190
License (as archived)
solo-consultazione
Archived
2026-11-08T09:59:49.171Z
SHA-256 of the archived text
f8dbb1c15f4d7a4e72263853a1def37d92945d54305b0ad8930b553ee15aa698
Stable URL of this page
https://metraipolis.com/documento/dc_bb82169d4aea

How to cite

New-Onset Autoantibody-Negative Diabetes With DKA Following Lorlatinib Therapy for ALK-Positive NSCLC — Europe PMC PMID:41322009 — Europe PMC (en), https://europepmc.org/article/MED/41322009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb82169d4aea (Metraipolis archive dc_bb82169d4aea, sha256 f8dbb1c15f4d7a4e72263853a1def37d92945d54305b0ad8930b553ee15aa698)
BibTeX
@misc{dcbb82169d4aea,
  title = {New-Onset Autoantibody-Negative Diabetes With DKA Following Lorlatinib Therapy for ALK-Positive NSCLC — Europe PMC PMID:41322009},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322009},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb82169d4aea; sha256 f8dbb1c15f4d7a4e72263853a1def37d92945d54305b0ad8930b553ee15aa698},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322009. Agents can read the archived copy with the MCP tool read_document.